Published in Diabetes Care on April 14, 2009
Accurate quantitative measurements of brachial artery cross-sectional vascular area and vascular volume elastic modulus using automated oscillometric measurements: comparison with brachial artery ultrasound. Hypertens Res (2015) 0.83
Diagnostic Accuracy Study of an Oscillometric Ankle-Brachial Index in Peripheral Arterial Disease: The Influence of Oscillometric Errors and Calcified Legs. PLoS One (2016) 0.82
Automated ankle-brachial pressure index measurement by clinical staff for peripheral arterial disease diagnosis in nondiabetic and diabetic patients: response to clairotte et Al. Diabetes Care (2010) 0.77
Different methods of calculating ankle-brachial index in mid-elderly men and women: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Braz J Med Biol Res (2016) 0.75
Detection of peripheral arterial disease with an improved automated device: comparison of a new oscillometric device and the standard Doppler method. Vasc Health Risk Manag (2016) 0.75
The Validity and Reliability between Automated Oscillometric Measurement of Ankle-Brachial Index and Standard Measurement by Eco-Doppler in Diabetic Patients with or without Diabetic Foot. Int J Endocrinol (2017) 0.75
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41
Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA (2001) 13.65
Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med (2000) 6.86
Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation (2004) 6.15
Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care (2004) 3.46
Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol (2005) 2.75
Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation (2006) 2.50
ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol (1996) 2.46
Utility and barriers to performance of the ankle-brachial index in primary care practice. Vasc Med (2004) 1.57
The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study, 1987-2001. BMC Cardiovasc Disord (2007) 1.45
Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care (2007) 1.39
Automated oscillometric determination of the ankle-brachial index provides accuracy necessary for office practice. Hypertension (2005) 1.38
Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care (2002) 1.30
The diagnostic value of the measurement of the ankle-brachial systolic pressure index in primary health care. J Clin Epidemiol (1996) 1.19
Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study. Diabetes Care (2006) 1.02
Validation of a new method of detecting peripheral artery disease by determination of ankle-brachial index using an automatic blood pressure device. Angiology (2004) 1.00
Clinical evaluation of semiautomatic and automatic devices for home blood pressure measurement: comparison between cuff-oscillometric and microphone methods. J Hypertens (1989) 0.88
Comparison of three measures of the ankle-brachial blood pressure index in a general population. Hypertens Res (2007) 0.87
Feasibility and reliability of ankle/arm blood pressure index in preventive medicine. Angiology (2000) 0.83
Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart. Circulation (2005) 2.75
Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet (2012) 2.15
Risk factors for Enterobacteriaceae bacteremia after liver transplantation. Transpl Int (2008) 2.06
New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet (2012) 1.79
Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis. Circulation (2005) 1.69
Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice. Circulation (2004) 1.67
The association between cystatin C and incident type 2 diabetes is related to central adiposity. Nephrol Dial Transplant (2013) 1.49
Aortic arch atheroma in transient ischemic attack patients. Atherosclerosis (2013) 1.43
Transforming growth factor-beta 1 increases glucocorticoid binding and signaling in macrophages through a Smad- and activated protein-1-mediated process. Kidney Int (2003) 1.41
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0. Comput Methods Programs Biomed (2009) 1.38
Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene. J Biol Chem (2002) 1.27
Elastin haploinsufficiency induces alternative aging processes in the aorta. Rejuvenation Res (2008) 1.26
Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. J Infect Dis (2009) 1.23
Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice. J Clin Invest (2007) 1.23
Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease. Nephrol Dial Transplant (2007) 1.17
Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias. Circulation (2005) 1.15
Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias. Circulation (2004) 1.12
Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats. Am J Physiol Heart Circ Physiol (2002) 1.12
The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy. FASEB J (2009) 1.12
The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects. Hum Mol Genet (2009) 1.09
Increases in waist circumference and weight as predictors of type 2 diabetes in individuals with impaired fasting glucose: influence of baseline BMI: data from the DESIR study. Diabetes Care (2010) 1.05
Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling. Circulation (2008) 1.04
Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling. Hypertension (2008) 1.04
The use of simulated annealing for finding optimal population designs. Comput Methods Programs Biomed (2002) 1.03
Population pharmacokinetics and pharmacodynamics of enoxaparin in unstable angina and non-ST-segment elevation myocardial infarction. Br J Clin Pharmacol (2003) 1.01
Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes. Proc Natl Acad Sci U S A (2002) 0.98
An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart. Cardiovasc Res (2013) 0.98
Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis. Eur Heart J (2012) 0.98
Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study. Diabetes Care (2004) 0.96
Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block. FASEB J (2007) 0.95
WNK1 regulates vasoconstriction and blood pressure response to α 1-adrenergic stimulation in mice. Hypertension (2011) 0.95
Effects of type of smoking (pipe, cigars or cigarettes) on biological indices of tobacco exposure and toxicity. Lung Cancer (2006) 0.92
Fibrillin-1 genetic deficiency leads to pathological ageing of arteries in mice. J Pathol (2011) 0.92
Locally expressed IGF1 propeptide improves mouse heart function in induced dilated cardiomyopathy by blocking myocardial fibrosis and SRF-dependent CTGF induction. Dis Model Mech (2012) 0.91
What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications? PLoS One (2013) 0.90
beta-Liddle mutation of the epithelial sodium channel increases alveolar fluid clearance and reduces the severity of hydrostatic pulmonary oedema in mice. J Physiol (2007) 0.90
Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes. Cardiovasc Diabetol (2015) 0.90
Prediction of shrinkage of individual parameters using the bayesian information matrix in non-linear mixed effect models with evaluation in pharmacokinetics. Pharm Res (2013) 0.90
Cause-specific mortality in diabetes: recent changes in trend mortality. Eur J Prev Cardiol (2012) 0.89
Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in type 2 diabetes. Diabetes Care (2011) 0.89
Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria. Diabetes Care (2013) 0.88
Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort. Diabetes Care (2014) 0.88
Hyperadiponectinemia is independent of kidney function, diabetes duration, and control in type 1 diabetic patients without microangiopathy. J Clin Endocrinol Metab (2010) 0.87
Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetes. J Pharmacol Exp Ther (2013) 0.86
Mosaic inactivation of the serum response factor gene in the myocardium induces focal lesions and heart failure. Eur J Heart Fail (2008) 0.86
Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study. Am J Nephrol (2015) 0.85
Mineralocorticoid receptor mutations and a severe recessive pseudohypoaldosteronism type 1. J Am Soc Nephrol (2011) 0.85
Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in type 2 diabetic subjects. Mol Genet Metab (2012) 0.84
Calcyclin is an early vasopressin-induced gene in the renal collecting duct. Role in the long term regulation of ion transport. J Biol Chem (2002) 0.84
Associations of the -344 T>C and the 3097 G>A polymorphisms of CYP11B2 gene with hypertension, type 2 diabetes, and metabolic syndrome in a French population. Am J Hypertens (2010) 0.84
Association of 2238T>C polymorphism of the atrial natriuretic peptide gene with coronary artery disease in Afro-Caribbeans with type 2 diabetes. Am J Hypertens (2011) 0.84
Enhanced sensitivity to low dose irradiation of ApoE-/- mice mediated by early pro-inflammatory profile and delayed activation of the TGFβ1 cascade involved in fibrogenesis. PLoS One (2013) 0.84
Coronary endothelial dysfunction after cardiomyocyte-specific mineralocorticoid receptor overexpression. Am J Physiol Heart Circ Physiol (2011) 0.84
Effects of genetic susceptibility for type 2 diabetes on the evolution of glucose homeostasis traits before and after diabetes diagnosis: data from the D.E.S.I.R. Study. Diabetes (2011) 0.83
Indinavir trough concentration as a determinant of early nephrolithiasis in HIV-1-infected adults. Ther Drug Monit (2007) 0.83
Respective effects of early cerebral and abdominal magnetic resonance imaging on clinical decisions in infective endocarditis. Eur Heart J Cardiovasc Imaging (2012) 0.83
SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes. Diabetologia (2014) 0.82
Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. Mol Genet Metab (2011) 0.82
Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman. J Clin Endocrinol Metab (2011) 0.82
Activation of the hypothalamic-pituitary-adrenal axis in adults with mineralocorticoid receptor haploinsufficiency. J Clin Endocrinol Metab (2014) 0.81
Fetal exposure to maternal type 1 diabetes is associated with renal dysfunction at adult age. Diabetes (2010) 0.81
Ankle-to-brachial ratio index underestimates the prevalence of peripheral occlusive disease in diabetic patients at high risk for arterial disease. Diabetes Care (2009) 0.81
Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts. Diabetologia (2013) 0.81
Genetic variability at the six transmembrane protein of prostate 2 locus and the metabolic syndrome: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. J Clin Endocrinol Metab (2010) 0.80
Cardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry disease. PLoS One (2012) 0.80
Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes. Diabetologia (2016) 0.79
Percutaneous intracoronary delivery of SERCA gene increases myocardial function: a tissue Doppler imaging echocardiographic study. Am J Physiol Heart Circ Physiol (2006) 0.79
The epidermal growth factor receptor is involved in angiotensin II but not aldosterone/salt-induced cardiac remodelling. PLoS One (2012) 0.79
Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes. Nephrol Dial Transplant (2010) 0.79
Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats. Diabetologia (2015) 0.79
Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies. J Hypertens (2016) 0.78
Association of common variants in NPPA and NPPB with blood pressure does not translate into kidney damage in a general population study. J Hypertens (2010) 0.78
Delayed cardiomyopathy in dystrophin deficient mdx mice relies on intrinsic glutathione resource. Am J Pathol (2010) 0.78
Asymptomatic myocardial ischemic disease in antiphospholipid syndrome: a controlled cardiac magnetic resonance imaging study. Arthritis Rheum (2010) 0.78
Tissue kallikrein, blood pressure regulation, and hypertension: insight from genetic kallikrein deficiency. Biol Chem (2013) 0.78
Glucose control in critically ill patients. N Engl J Med (2009) 0.78
Survival as a function of HbA(1c) in people with type 2 diabetes. Lancet (2010) 0.78
Tissue kallikrein deficiency, insulin resistance, and diabetes in mouse and man. J Endocrinol (2014) 0.77
Effect of long-term heart rate reduction by If current inhibition on pressure overload-induced heart failure in rats. J Pharmacol Exp Ther (2007) 0.77
Epo deficiency alters cardiac adaptation to chronic hypoxia. Respir Physiol Neurobiol (2013) 0.77
Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes. Diabetologia (2013) 0.77
NMR-based prediction of cardiovascular risk in diabetes. Nat Med (2007) 0.77
Cryoglobulin-induced cardiomyopathy. J Am Coll Cardiol (2010) 0.76
Reduced insulin secretion and nocturnal dipping of blood pressure are associated with a disturbed circadian pattern of urine excretion in metabolic syndrome. J Clin Endocrinol Metab (2011) 0.76
Potassium channel openers increase aortic elastic fiber formation and reverse the genetically determined elastin deficit in the BN rat. Hypertension (2013) 0.76
Kinins as therapeutic agents in cardiovascular and renal diseases. Curr Pharm Des (2011) 0.76
Increased activity of the diastrophic dysplasia sulfate transporter in otosclerosis and its inhibition by sodium fluoride. Otol Neurotol (2003) 0.76
Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse. Endocrinology (2012) 0.75
Association Between Diabetic Macular Edema and Cardiovascular Events in Type 2 Diabetes Patients: A Multicenter Observational Study. Medicine (Baltimore) (2015) 0.75
A Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. N Engl J Med (2015) 0.75
Overweight Is a Major Contributor to Atherosclerosis in Systemic Lupus Erythematosus Patients at Apparent Low Risk for Cardiovascular Disease: A Cross-Sectional Controlled Study. Medicine (Baltimore) (2015) 0.75
Kallikrein(K1)-kinin-kininase (ACE) and end-organ damage in ischemia and diabetes: therapeutic implications. Biol Chem (2016) 0.75